Annual EBIT
-$242.16 M
-$71.20 M-41.65%
31 December 2023
Summary:
Dyne Therapeutics annual earnings before interest & taxes is currently -$242.16 million, with the most recent change of -$71.20 million (-41.65%) on 31 December 2023. During the last 3 years, it has fallen by -$183.12 million (-310.16%). DYN annual EBIT is now -4933.51% below its all-time high of -$4.79 million.DYN EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$105.66 M
-$33.70 M-46.83%
30 September 2024
Summary:
Dyne Therapeutics quarterly earnings before interest & taxes is currently -$105.66 million, with the most recent change of -$33.70 million (-46.83%) on 30 September 2024. Over the past year, it has dropped by -$43.39 million (-69.67%). DYN quarterly EBIT is now -1855.56% below its all-time high of -$5.40 million, reached on 31 December 2019.DYN Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$314.47 M
-$43.39 M-16.00%
30 September 2024
Summary:
Dyne Therapeutics TTM earnings before interest & taxes is currently -$314.47 million, with the most recent change of -$43.39 million (-16.00%) on 30 September 2024. Over the past year, it has dropped by -$99.85 million (-46.52%). DYN TTM EBIT is now -5256.26% below its all-time high of -$5.87 million, reached on 30 September 2019.DYN TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -41.6% | -69.7% | -46.5% |
| 3 y3 years | -310.2% | -147.1% | -148.3% |
| 5 y5 years | -4933.5% | -1699.7% | -5256.3% |
DYN EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -310.2% | at low | -195.3% | at low | -148.3% | at low |
| 5 y | 5 years | -4933.5% | at low | -1855.6% | at low | -5256.3% | at low |
| alltime | all time | -4933.5% | at low | -1855.6% | at low | -5256.3% | at low |
Dyne Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$105.66 M(+46.8%) | -$314.47 M(+16.0%) |
| June 2024 | - | -$71.96 M(+4.1%) | -$271.08 M(+2.0%) |
| Mar 2024 | - | -$69.16 M(+2.2%) | -$265.85 M(+9.8%) |
| Dec 2023 | -$242.16 M(+41.6%) | -$67.69 M(+8.7%) | -$242.16 M(+12.8%) |
| Sept 2023 | - | -$62.27 M(-6.7%) | -$214.62 M(+10.3%) |
| June 2023 | - | -$66.74 M(+46.8%) | -$194.62 M(+7.7%) |
| Mar 2023 | - | -$45.46 M(+13.2%) | -$180.64 M(+5.7%) |
| Dec 2022 | -$170.96 M(+14.0%) | -$40.15 M(-5.0%) | -$170.96 M(-6.5%) |
| Sept 2022 | - | -$42.28 M(-19.9%) | -$182.78 M(-0.3%) |
| June 2022 | - | -$52.76 M(+47.4%) | -$183.26 M(+14.1%) |
| Mar 2022 | - | -$35.78 M(-31.1%) | -$160.67 M(+7.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$150.03 M(+154.1%) | -$51.96 M(+21.5%) | -$150.03 M(+18.5%) |
| Sept 2021 | - | -$42.77 M(+41.8%) | -$126.63 M(+29.7%) |
| June 2021 | - | -$30.16 M(+20.0%) | -$97.66 M(+27.9%) |
| Mar 2021 | - | -$25.13 M(-12.0%) | -$76.35 M(+29.3%) |
| Dec 2020 | -$59.04 M(+297.3%) | -$28.57 M(+107.2%) | -$59.04 M(+64.6%) |
| Sept 2020 | - | -$13.79 M(+55.7%) | -$35.88 M(+28.3%) |
| June 2020 | - | -$8.86 M(+13.1%) | -$27.96 M(+46.4%) |
| Mar 2020 | - | -$7.83 M(+44.9%) | -$19.10 M(+69.4%) |
| Dec 2019 | -$14.86 M(+208.9%) | -$5.40 M(-8.0%) | -$11.27 M(+92.0%) |
| Sept 2019 | - | -$5.87 M | -$5.87 M |
| Dec 2018 | -$4.81 M | - | - |
FAQ
- What is Dyne Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics annual EBIT year-on-year change?
- What is Dyne Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly EBIT year-on-year change?
- What is Dyne Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Dyne Therapeutics?
- What is Dyne Therapeutics TTM EBIT year-on-year change?
What is Dyne Therapeutics annual earnings before interest & taxes?
The current annual EBIT of DYN is -$242.16 M
What is the all time high annual EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high annual earnings before interest & taxes is -$4.79 M
What is Dyne Therapeutics annual EBIT year-on-year change?
Over the past year, DYN annual earnings before interest & taxes has changed by -$71.20 M (-41.65%)
What is Dyne Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of DYN is -$105.66 M
What is the all time high quarterly EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly earnings before interest & taxes is -$5.40 M
What is Dyne Therapeutics quarterly EBIT year-on-year change?
Over the past year, DYN quarterly earnings before interest & taxes has changed by -$43.39 M (-69.67%)
What is Dyne Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of DYN is -$314.47 M
What is the all time high TTM EBIT for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM earnings before interest & taxes is -$5.87 M
What is Dyne Therapeutics TTM EBIT year-on-year change?
Over the past year, DYN TTM earnings before interest & taxes has changed by -$99.85 M (-46.52%)